288 related articles for article (PubMed ID: 36768472)
1. Clinical Trials in Prader-Willi Syndrome: A Review.
Mahmoud R; Kimonis V; Butler MG
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768472
[TBL] [Abstract][Full Text] [Related]
2. Prader-Willi Syndrome: Clinical Genetics and Diagnostic Aspects with Treatment Approaches.
Butler MG; Manzardo AM; Forster JL
Curr Pediatr Rev; 2016; 12(2):136-66. PubMed ID: 26592417
[TBL] [Abstract][Full Text] [Related]
3. The Prader-Willi syndrome Profile: validation of a new measure of behavioral and emotional problems in Prader-Willi syndrome.
Dykens EM; Roof E; Hunt-Hawkins H
Orphanet J Rare Dis; 2024 Feb; 19(1):83. PubMed ID: 38395848
[TBL] [Abstract][Full Text] [Related]
4. Disentangling ingestive behavior-related phenotypes in Prader-Willi syndrome: Integrating information from nonclinical studies and clinical trials to better understand the pathophysiology of hyperphagia and obesity.
Wevrick R
Physiol Behav; 2020 May; 219():112864. PubMed ID: 32156555
[TBL] [Abstract][Full Text] [Related]
5. Calorie seeking, but not hedonic response, contributes to hyperphagia in a mouse model for Prader-Willi syndrome.
Davies JR; Humby T; Dwyer DM; Garfield AS; Furby H; Wilkinson LS; Wells T; Isles AR
Eur J Neurosci; 2015 Aug; 42(4):2105-13. PubMed ID: 26040449
[TBL] [Abstract][Full Text] [Related]
6. Diazoxide Choline Extended-Release Tablet in People With Prader-Willi Syndrome: A Double-Blind, Placebo-Controlled Trial.
Miller JL; Gevers E; Bridges N; Yanovski JA; Salehi P; Obrynba KS; Felner EI; Bird LM; Shoemaker AH; Angulo M; Butler MG; Stevenson D; Abuzzahab J; Barrett T; Lah M; Littlejohn E; Mathew V; Cowen NM; Bhatnagar A;
J Clin Endocrinol Metab; 2023 Jun; 108(7):1676-1685. PubMed ID: 36639249
[TBL] [Abstract][Full Text] [Related]
7. Prader-Willi Syndrome: Obesity due to Genomic Imprinting.
Butler MG
Curr Genomics; 2011 May; 12(3):204-15. PubMed ID: 22043168
[TBL] [Abstract][Full Text] [Related]
8. Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings.
Angulo MA; Butler MG; Cataletto ME
J Endocrinol Invest; 2015 Dec; 38(12):1249-63. PubMed ID: 26062517
[TBL] [Abstract][Full Text] [Related]
9. The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria.
Gunay-Aygun M; Schwartz S; Heeger S; O'Riordan MA; Cassidy SB
Pediatrics; 2001 Nov; 108(5):E92. PubMed ID: 11694676
[TBL] [Abstract][Full Text] [Related]
10. A randomized pilot efficacy and safety trial of diazoxide choline controlled-release in patients with Prader-Willi syndrome.
Kimonis V; Surampalli A; Wencel M; Gold JA; Cowen NM
PLoS One; 2019; 14(9):e0221615. PubMed ID: 31545799
[TBL] [Abstract][Full Text] [Related]
11. Prader-Willi Syndrome - Clinical Genetics, Diagnosis and Treatment Approaches: An Update.
Butler MG; Miller JL; Forster JL
Curr Pediatr Rev; 2019; 15(4):207-244. PubMed ID: 31333129
[TBL] [Abstract][Full Text] [Related]
12. Hypomethylation of the dopamine transporter (DAT) gene promoter is associated with hyperphagia-related behavior in Prader-Willi syndrome: A case-control study.
Wieting J; Jahn K; Eberlein CK; Bleich S; Frieling H; Deest M
Behav Brain Res; 2023 Jul; 450():114494. PubMed ID: 37182741
[TBL] [Abstract][Full Text] [Related]
13. Expression of 4 genes between chromosome 15 breakpoints 1 and 2 and behavioral outcomes in Prader-Willi syndrome.
Bittel DC; Kibiryeva N; Butler MG
Pediatrics; 2006 Oct; 118(4):e1276-83. PubMed ID: 16982806
[TBL] [Abstract][Full Text] [Related]
14. Psychotic illness in people with Prader-Willi syndrome: a systematic review of clinical presentation, course and phenomenology.
Aman LCS; Lester SD; Holland AJ; Fletcher PC
Orphanet J Rare Dis; 2024 Feb; 19(1):69. PubMed ID: 38360662
[TBL] [Abstract][Full Text] [Related]
15. Transcranial direct current stimulation reduces food-craving and measures of hyperphagia behavior in participants with Prader-Willi syndrome.
Bravo GL; Poje AB; Perissinotti I; Marcondes BF; Villamar MF; Manzardo AM; Luque L; LePage JF; Stafford D; Fregni F; Butler MG
Am J Med Genet B Neuropsychiatr Genet; 2016 Mar; 171B(2):266-75. PubMed ID: 26590516
[TBL] [Abstract][Full Text] [Related]
16. Alteration of serum leptin and LEP/LEPR promoter methylation in Prader-Willi syndrome.
Wieting J; Jahn K; Buchholz V; Lichtinghagen R; Deest-Gaubatz S; Bleich S; Eberlein CK; Deest M; Frieling H
Psychoneuroendocrinology; 2022 Sep; 143():105857. PubMed ID: 35803048
[TBL] [Abstract][Full Text] [Related]
17. Obesity in Prader-Willi syndrome: physiopathological mechanisms, nutritional and pharmacological approaches.
Muscogiuri G; Barrea L; Faggiano F; Maiorino MI; Parrillo M; Pugliese G; Ruggeri RM; Scarano E; Savastano S; Colao A;
J Endocrinol Invest; 2021 Oct; 44(10):2057-2070. PubMed ID: 33891302
[TBL] [Abstract][Full Text] [Related]
18. A disease specific questionnaire for assessing behavior in individuals with Prader-Willi syndrome.
Avrahamy H; Pollak Y; Shriki-Tal L; Genstil L; Hirsch HJ; Gross-Tsur V; Benarroch F
Compr Psychiatry; 2015 Apr; 58():189-97. PubMed ID: 25677112
[TBL] [Abstract][Full Text] [Related]
19. Three siblings with Prader-Willi syndrome caused by imprinting center microdeletions and review.
Hartin SN; Hossain WA; Weisensel N; Butler MG
Am J Med Genet A; 2018 Apr; 176(4):886-895. PubMed ID: 29437285
[TBL] [Abstract][Full Text] [Related]
20. Prader-Willi syndrome: Hormone therapies.
Tauber M; Diene G
Handb Clin Neurol; 2021; 181():351-367. PubMed ID: 34238470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
